November 18th, 2026Low CRC Incidence Found After Endoscopic Mucosal ResectionCRC diagnoses after endoscopic mucosal resection (EMR) were uncommon in a real-world cohort, though racial and ethnic differences remain unclear.Read more
November 17th, 2026Atopic Dermatitis Escalation Stalls on Payer Rules, Thin TrackingSan Francisco experts say payer step edits and weak biologic follow-up slow atopic dermatitis care and point to pharmacy teams and dashboards.Read more
November 17th, 2026Real-World Data Support Cemiplimab Efficacy in Advanced NSCLCIn this Q&A, Jesús Corral Jaime, MD, discusses real-world CEMI-LUNG data on cemiplimab in advanced NSCLC presented at the ESMO 2026 Congress.Read more
November 20th, 2026Health Equity & Access Weekly Roundup: November 20, 2026Employer diabetes guide; Camden psychedelic therapy input; CRC after EMR; rural HFrEF care; JAMA obesity report.Read more
November 19th, 2026Most Patients With Psoriasis Screened Positive for PsA at One Dermatology ClinicIn a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated questionnaire.Read more
November 18th, 2026FDA Approves Secukinumab as First Anti–IL-17 Biologic for PMRThe FDA has approved secukinumab for PMR after the REPLENISH trial showed doubled sustained remission and lower steroid use vs a steroid taper alone.Read more
November 17th, 2026FDA Grants Accelerated Approval to Neladalkib for Previously Treated ALK-Positive NSCLCNeladalkib earned accelerated approval for previously treated ALK-positive NSCLC, with ORRs of 49% and 32%.Read more
November 17th, 2026Precision Medicine Equity Hinges on Systems, but Coverage Gaps Linger Panelists concurred that precision medicine can serve to exacerbate care inequality if not everyone can access these therapeutics. Read more